All diagnostic results from our panels are automatically entered into our variant reclassification program. This program supports the identification of new genetic evidence. We notify physicians automatically and free of charge if a new classification has an impact on a previous diagnosis.
New disease-causing variants are identified every year. Consequently, classifying variants is an on ongoing process. At CENTOGENE, we have a dedicated team of experts who monitor medical literature and update our Bio/Databank accordingly. We use internationally recognized American College of Medical Genetics and Genomics (ACMG) guidelines to evaluate new evidence. We combine it with our patient data to make informed decisions when classifying newly identified genetic variants.
Once a variant is classified, every new observation, whether via internal or external research, is monitored and used to also re-evaluate past classification decisions systematically. New evidence can sometimes suggest a change in diagnosis or treatment. We communicate all re-classification decisions to our referring physicians, and any re-classification affecting a genetic diagnosis is shared as soon as possible.
- Proactive notification of every patient affected by the reclassification
- Based on a unique combination of broad patient data - genetic, biochemical, and clinical
- Variant data derived from a large and diverse cohort of patients
- Stringent data curation and validation process
Variant Reclassification: When, Why, How
Discover how CENTOGENE’s variant reclassification enables us to provide you with the latest and highest quality data for the most up-to-date diagnosis.
What You Need to Know about Carrier Screening
Carrier screening is a predictive genetic testing, designed for future parents. Would you like to learn more and understand it better? Watch our recorded webinar about CentoScreen®: "What you need to […]
Clinical Exome Sequencing Targets Genes Associated with All Known Clinical Phenotypes
Watch our recorded webinar, “Clinical Exome Sequencing targets genes associated with all known clinical phenotypes to achieve high diagnostic accuracy” and find out how clinical utility meets patient […]